HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
1326studies shown
Showing 961-972 of 1,326
Drug study icon
CompletedNCT01151696

Pain and Anxiety Management of Traumatic Emergency in a Pre-hospital Setting

Official study title

Prise en Charge Pharmacologique de l'anxiété et de la Douleur Chez Les Patients Qui Souffrent en Situation d'Urgence Traumatique pré-hospitalière : étude randomisée contrôlée en Double Aveugle

This study has finished and is no longer accepting participants.

In France
AnxietyMedication studyAges 18+
Countries
France
Sponsor
University Hospital, Toulouse
Other study type icon
TerminatedNCT01244542

Pain and Schizophrenia

This study ended early.

In France
SchizophreniaInterventional studyAges 18–55
Countries
France
Sponsor
University Hospital, Strasbourg, France
Drug study icon
CompletedNCT01281527

Paliperidone Palmitate Flexible Dosing in Schizophrenia

What is this study about?

Researchers studied Paliperidone Palmitate to find out how it affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

In France
SchizophreniaMedication studyAges 18+
Countries
France, United Kingdom, Switzerland, + 17 others
Sponsor
Janssen-Cilag International NV
Other study type icon
UnknownNCT06616337

Patients Suffering From Emotional Dysregulation

Official study title

Retrospective Study of the Acceptability and Effectiveness of a Dialectical Behavioral Therapy Group in Patients Suffering From Emotional Dysregulation (Borderline Personality Disorder, Bipolar Disorder and Adult ADHD)

Current recruitment status is unconfirmed.

In France
Personality disordersObservational studyAges 18+
Countries
France
Sponsor
University Hospital, Strasbourg, France
Drug study icon
CompletedNCT01435928

PEARL Schizophrenia Maintenance

Official study title

A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia

This study has finished and is no longer accepting participants.

In France
SchizophreniaMedication studyAges 18–75
Countries
France, United States, Italy, + 4 others
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT01914393

Pediatric Extension Study

Official study title

A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects

This study has finished and is no longer accepting participants.

In France
Schizophrenia, Bipolarity, ...Medication studyAges 6–17
Countries
France, United States, Bulgaria, + 11 others
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT01911429

Pediatric Schizophrenia Efficacy and Safety Study

What is this study about?

Researchers compared Lurasidone 40 mg, Lurasidone 80 mg and placebo to find out how the approaches affected psychotic symptoms in young people with schizophrenia.

This study has finished and is no longer accepting participants.

In France
SchizophreniaMedication studyAges 13–17
Countries
France, United States, United Kingdom, + 13 others
Sponsor
Sumitomo Pharma America, Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.